136 related articles for article (PubMed ID: 14611859)
1. Two antiviral compounds from the plant Stylogne cauliflora as inhibitors of HCV NS3 protease.
Hegde VR; Pu H; Patel M; Das PR; Butkiewicz N; Arreaza G; Gullo VP; Chan TM
Bioorg Med Chem Lett; 2003 Sep; 13(17):2925-8. PubMed ID: 14611859
[TBL] [Abstract][Full Text] [Related]
2. Antiviral compounds from traditional Chinese medicines Galla Chinese as inhibitors of HCV NS3 protease.
Duan D; Li Z; Luo H; Zhang W; Chen L; Xu X
Bioorg Med Chem Lett; 2004 Dec; 14(24):6041-4. PubMed ID: 15546725
[TBL] [Abstract][Full Text] [Related]
3. Screening of antiviral activities in medicinal plants extracts against dengue virus using dengue NS2B-NS3 protease assay.
Rothan HA; Zulqarnain M; Ammar YA; Tan EC; Rahman NA; Yusof R
Trop Biomed; 2014 Jun; 31(2):286-96. PubMed ID: 25134897
[TBL] [Abstract][Full Text] [Related]
4. Identification of a 3-Alkylpyridinium Compound from the Red Sea Sponge
O'Rourke A; Kremb S; Duggan BM; Sioud S; Kharbatia N; Raji M; Emwas AH; Gerwick WH; Voolstra CR
Molecules; 2018 Jun; 23(6):. PubMed ID: 29912151
[TBL] [Abstract][Full Text] [Related]
5. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.
Bachmetov L; Gal-Tanamy M; Shapira A; Vorobeychik M; Giterman-Galam T; Sathiyamoorthy P; Golan-Goldhirsh A; Benhar I; Tur-Kaspa R; Zemel R
J Viral Hepat; 2012 Feb; 19(2):e81-8. PubMed ID: 22239530
[TBL] [Abstract][Full Text] [Related]
6. Peptide inhibitors of hepatitis C virus NS3 protease.
Portal-Núñez S; González-Navarro CJ; García-Delgado M; Vizmanos JL; Lasarte JJ; Borrás-Cuesta F
Antivir Chem Chemother; 2003 Sep; 14(5):225-33. PubMed ID: 14694985
[TBL] [Abstract][Full Text] [Related]
7. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.
Stoermer MJ; Chappell KJ; Liebscher S; Jensen CM; Gan CH; Gupta PK; Xu WJ; Young PR; Fairlie DP
J Med Chem; 2008 Sep; 51(18):5714-21. PubMed ID: 18729351
[TBL] [Abstract][Full Text] [Related]
8. A review of HCV protease inhibitors.
Chen KX; Njoroge FG
Curr Opin Investig Drugs; 2009 Aug; 10(8):821-37. PubMed ID: 19649927
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the inhibitory effect of eight compounds from
Wei Y; Yang J; Kishore Sakharkar M; Wang X; Liu Q; Du J; Zhang JJ
Nat Prod Res; 2020 Jun; 34(11):1607-1610. PubMed ID: 30449158
[TBL] [Abstract][Full Text] [Related]
10. Isolation and structure of SCH 351633: a novel hepatitis C virus (HCV) NS3 protease inhibitor from the fungus Penicillium griseofulvum.
Chu M; Mierzwa R; He L; King A; Patel M; Pichardo J; Hart A; Butkiewicz N; Puar MS
Bioorg Med Chem Lett; 1999 Jul; 9(14):1949-52. PubMed ID: 10450960
[TBL] [Abstract][Full Text] [Related]
11. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein-ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation.
El-Hasab MAE; El-Bastawissy EE; El-Moselhy TF
J Biomol Struct Dyn; 2018 May; 36(7):1713-1727. PubMed ID: 28531373
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of bicyclic pyrimidinone-based HCV NS3 protease inhibitors.
Glunz PW; Douty BD; Decicco CP
Bioorg Med Chem Lett; 2003 Mar; 13(5):785-8. PubMed ID: 12617891
[TBL] [Abstract][Full Text] [Related]
14. Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
Dahl G; Sandström A; Akerblom E; Danielson UH
Antivir Ther; 2007; 12(5):733-40. PubMed ID: 17713156
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibitors of HCV-NS3 protease derived from boronic acids.
Venkatraman S; Wu W; Prongay A; Girijavallabhan V; George Njoroge F
Bioorg Med Chem Lett; 2009 Jan; 19(1):180-3. PubMed ID: 19022670
[TBL] [Abstract][Full Text] [Related]
16. Pyrrolidine-5,5-trans-lactams. 4. Incorporation of a P3/P4 urea leads to potent intracellular inhibitors of hepatitis C virus NS3/4A protease.
Slater MJ; Amphlett EM; Andrews DM; Bamborough P; Carey SJ; Johnson MR; Jones PS; Mills G; Parry NR; Somers DO; Stewart AJ; Skarzynski T
Org Lett; 2003 Nov; 5(24):4627-30. PubMed ID: 14627400
[TBL] [Abstract][Full Text] [Related]
17. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of BILN 2061, an HCV NS3 protease inhibitor with proven antiviral effect in humans.
Faucher AM; Bailey MD; Beaulieu PL; Brochu C; Duceppe JS; Ferland JM; Ghiro E; Gorys V; Halmos T; Kawai SH; Poirier M; Simoneau B; Tsantrizos YS; Llinàs-Brunet M
Org Lett; 2004 Aug; 6(17):2901-4. PubMed ID: 15330643
[TBL] [Abstract][Full Text] [Related]
19. Structure-based drug design of novel peptidomimetic cellulose derivatives as HCV-NS3 protease inhibitors.
Saleh NA; Elshemey WM
Life Sci; 2017 Oct; 187():58-63. PubMed ID: 28842311
[TBL] [Abstract][Full Text] [Related]
20. Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection.
Tsantrizos YS; Bolger G; Bonneau P; Cameron DR; Goudreau N; Kukolj G; LaPlante SR; Llinàs-Brunet M; Nar H; Lamarre D
Angew Chem Int Ed Engl; 2003 Mar; 42(12):1356-60. PubMed ID: 12671967
[No Abstract] [Full Text] [Related]
[Next] [New Search]
